Established and emerging uses of cytoprotection in head and neck cancer
- PMID: 16490868
- DOI: 10.1001/archotol.132.2.129
Established and emerging uses of cytoprotection in head and neck cancer
Comment on
-
Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy.Arch Otolaryngol Head Neck Surg. 2006 Feb;132(2):141-5. doi: 10.1001/archotol.132.2.141. Arch Otolaryngol Head Neck Surg. 2006. PMID: 16490870
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
